Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)

Summary Malignant solitary fibrous tumors are rare soft-tissue sarcomas. They are considered as low-grade malignancies, but may display metastatic potential in 20 % of the cases. In case of metastatic or locally advanced, unresectable disease, standard treatments, like anthracycline-based regimens,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigational new drugs 2013-12, Vol.31 (6), p.1626-1627
Hauptverfasser:	Valentin, T., Fournier, C., Penel, N., Bompas, E., Chaigneau, L., Isambert, N., Chevreau, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Agents - therapeutic use Biological and medical sciences Cancer Cancer therapies Chemotherapy Conflicts of interest Dermatology Disease control Drug dosages Drug therapy Female Humans Male Medical sciences Medicine Medicine & Public Health Metastasis Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Niacinamide - analogs & derivatives Niacinamide - therapeutic use Oncology Patients Pharmaceuticals Pharmacology. Drug treatments Pharmacology/Toxicology Phenylurea Compounds - therapeutic use Protein Kinase Inhibitors - therapeutic use Sarcoma Short Report Solitary Fibrous Tumors - drug therapy Studies Toxicity Treatment Outcome Tumors Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!